Skip to main content
. 2009 Aug 7;24(12):3794–3799. doi: 10.1093/ndt/gfp372

Table 2.

End of treatment serum calcium × phosphorus product and lipids

Laboratory parameter Sevelamer carbonate powder TID Sevelamer hydrochloride tablets TID P-value
Calcium × phosphorus product 0.749
 (mmol2/L2) (mg2/dL2)
 n 25 28
Mean ± SD 3.7 ± 1.1 (45.9 ± 13.8) 3.7 ± 0.8 (45.8 ± 10.0)
Median 3.8 (46.6) 3.8 (46.9)
Total cholesterol (mmol/L) (mg/dL) 0.218
 n 22 27
Mean ± SD 3.5 ± 0.7 (135.4 ± 26.9) 3.3 ± 0.8 (129.1 ± 31.6)
Median 132 (3.4) 127 (3.3)
LDL cholesterol (mmol/L) (mg/dL) 0.109
 n 22 27
Mean ± SD 1.8 ± 0.5 (70.4 ± 18.3) 1.8 ± 0.7 (67.7 ± 25.4)
Median 67 (1.7) 65 (1.7)
HDL cholesterol (mmol/L) (mg/dL) 0.537
 n 22 27
Mean ± SD 1.2 ± 0.5 (44.5 ± 17.7) 1.1 ± 0.4 (43.7 ± 13.9)
Median 43 (1.1) 42 (1.1)
Triglycerides (mmol/L) (mg/dL) 0.992
 n 22 27
Mean ± SD 2.2 ± 1.6 (192.7 ± 139.6) 2.1 ± 1.5 (188.9 ± 131.9)
Median 144 (1.6) 142 (1.6)